Covered recipient · General Payments record
JULIA ARONS SIEGEL
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2022–2024
$1,593.60
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $758.00 | 26 |
| Education | $64.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $330.70 | 10 |
| ABBVIE INC. | $165.08 | 6 |
| Lilly USA, LLC | $82.27 | 3 |
| E.R. Squibb & Sons, L.L.C. | $74.43 | 2 |
| PFIZER INC. | $67.82 | 2 |
| Amgen Inc. | $34.80 | 1 |
| Incyte Corporation | $27.76 | 1 |
| Dermavant Sciences, Inc. | $22.46 | 1 |
| Galderma Laboratories, L.P. | $17.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.80 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106100391 | CMS |
| ABBVIE INC. | $29.17 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106100393 | CMS |
| ABBVIE INC. | $29.27 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106100395 | CMS |
| ABBVIE INC. | $34.76 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106100397 | CMS |
| ABBVIE INC. | $28.73 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106100399 | CMS |
| ABBVIE INC. | $10.35 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106100401 | CMS |
| Amgen Inc. | $34.80 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117382904 | CMS |
| Dermavant Sciences, Inc. | $22.46 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127933812 | CMS |
| E.R. Squibb & Sons, L.L.C. | $47.85 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101317634 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.58 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101317638 | CMS |
| Galderma Laboratories, L.P. | $17.63 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145328274 | CMS |
| Incyte Corporation | $27.76 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141176690 | CMS |
| Janssen Biotech, Inc. | $28.15 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078689786 | CMS |
| Janssen Biotech, Inc. | $12.03 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078690079 | CMS |
| Janssen Biotech, Inc. | $36.76 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078689071 | CMS |
| Janssen Biotech, Inc. | $64.95 | 03/29/2024 | Education | Undisputed | 01/23/2026 | 1078688653 | CMS |
| Janssen Biotech, Inc. | $32.26 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078689007 | CMS |
| Janssen Biotech, Inc. | $33.05 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078690018 | CMS |
| Janssen Biotech, Inc. | $23.77 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078690236 | CMS |
| Janssen Biotech, Inc. | $33.29 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078688105 | CMS |
| Janssen Biotech, Inc. | $33.29 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078690687 | CMS |
| Janssen Biotech, Inc. | $33.15 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078690623 | CMS |
| Lilly USA, LLC | $25.54 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135108964 | CMS |
| Lilly USA, LLC | $25.26 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135075285 | CMS |
| Lilly USA, LLC | $31.47 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135075287 | CMS |
| PFIZER INC. | $33.27 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131222744 | CMS |
| PFIZER INC. | $34.55 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131077251 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.